Gerstner G J
Wien Klin Wochenschr. 1983 Oct 28;95(20):708-18.
Infections in patients with gynecologic malignancies occur frequently and are the cause of death in 50 to 60% of the cases. The patient with cancer is a compromised host with an increased susceptibility to infection due to the malignancy itself on the one hand and due to therapeutic-modalities, like extensive surgical procedures, radiation- and cytotoxic chemotherapy on the other hand. Aetiologically these infections are mostly due to a disruption of anatomic structures which normally prevent the invasion of exogenous or endogenous microorganisms, or to obstructive processes or to tumour necrosis. Septicaemia can result from propagation of such a localized infection beyond the site of the tumour. The causative pathogens infecting the compromised host are mostly members of the indigenous microbial flora of the genital tract, which is influenced by surgery, irradiation and chemotherapy. Postoperatively in the vaginal vault the number of most potentially pathogenic aerobic and anaerobic bacterial species is higher, polymicrobial mixed infections are frequent. Neither the intracavitary radiation-therapy with Radium or Iridium-192 (afterloading) nor the external high-voltage therapy decrease the number of pathogenic bacterial species in the uterus and in the vagina of patients with cervical or endometrial cancer. The symptoms of infection in cancer patients can be "masked". Fever in patients with genital malignancies is mostly due to local infections and influences the prognosis negatively. The 5-year survival rate of irradiated patients with fever is significantly lower. Infections following radical hysterectomy, irradiation and/or cytotoxic chemotherapy like pelvic abscesses, peritonitis, pneumonia and septicaemia can be fatal. Urinary-tract-, wound- and vaginal vault-infections occur frequently, but are rarely severe. Therapeutically in severe infections a combination antibiotic therapy, which is effective against most pathogenic members of the genital flora, is required. Short courses of perioperative prophylactic antibiotics are useful both in radical hysterectomy and with intracavitary irradiation.
妇科恶性肿瘤患者感染频繁发生,是50%至60%病例的死亡原因。癌症患者是免疫功能受损的宿主,一方面由于恶性肿瘤本身,另一方面由于广泛手术、放疗和细胞毒性化疗等治疗方式,导致其对感染的易感性增加。从病因学角度来看,这些感染大多是由于正常情况下可防止外源性或内源性微生物入侵的解剖结构遭到破坏,或是由于阻塞性病变或肿瘤坏死。局部感染若扩散至肿瘤部位以外,可导致败血症。感染免疫功能受损宿主的致病病原体大多是生殖道固有微生物菌群的成员,而该菌群会受到手术、放疗和化疗的影响。术后阴道穹窿中大多数潜在致病性需氧菌和厌氧菌的数量增加,多微生物混合感染很常见。无论是镭或铱 - 192腔内放射治疗(后装)还是体外高压治疗,都不会减少宫颈癌或子宫内膜癌患者子宫和阴道内致病细菌的数量。癌症患者感染的症状可能会被“掩盖”。生殖系统恶性肿瘤患者发热大多是由于局部感染,对预后有负面影响。发热的放疗患者5年生存率显著较低。根治性子宫切除、放疗和/或细胞毒性化疗后的感染,如盆腔脓肿、腹膜炎、肺炎和败血症,可能是致命的。尿路感染、伤口感染和阴道穹窿感染很常见,但很少严重。在严重感染的治疗中,需要联合使用对生殖道菌群中大多数致病成员有效的抗生素治疗。围手术期短期预防性使用抗生素对根治性子宫切除和腔内放疗都有用。